Search

Issue
Title
Authors
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A.V., Verbovoy A.F.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.B.
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N.A., Kuzina I.A.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M.E., Derevyanchenko M.V.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A.S., Kulidzhanyan N.K., Shurupova I.V., Trifonova T.A., Antsiferov M.B.
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E.V., Antsiferov M.B., Biryukova Y.V., Antsiferov M.B.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y.V., Biryukova E.V.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V.V., Chazova I., Fomin V.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N.А., Baranova N.I., Fedin A.V.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E.V., Solovyova I.V.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N.A., Terekhova A.L.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E.V., Tyulganova V.L.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I.G., Vinnytskaya E.V., Sandler Y.G., Keiyan V.A., Rodionova S.V.
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M.S., Nazhmutdinova P.K., Ametov A.S.
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.B.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N.A., Trukhina L.V., Sinitsyna E.I., Antsiferov M.B.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A.F., Vorozhtsova E.I., Orlova T.N.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Brashchenkova A.V., Petunina N.A., Brashcenkova A.V.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E.V., pl?midmagidsid Y.h.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M.B., Koteshkova O.M., Kleimenova S.A., Antsiferov M.B., Koteshkova O.M., Kleymenova S.A.
Common bean (Phaseolus vulgaris L.)/
Samylina I.A., Sorokina A.A., Pyatigorskaya N.V., Samylina I., Sorokina A., Pyatigorskaya N.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M.S., Koteshkova O.M., Antsiferov M.B.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
Shevkunova N.A., Vorobyov M.V., Gushchin V.V.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L.A., Verbovoy A.F.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A.M., Podachina S.V., Sviridova M.I.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V.I., Nichitenko M.S., Chesnikova A.I.
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N.A., Ametov A.S., Antsiferov M.B.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Dorofeeva L.G.
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M.B., Ametov A.S., Zilov A.V., Antsiferov M.B., Ametov A.S., Zilov A.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.A.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S.S., Apetova V.V.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T.V., Lomonova T.V.
The many faces of vitamin D
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A.F., Lomonova T.V., Sharonova L.A.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Fadeev V.V., Morgunova T.B.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N.A., Zakharova S.K., Zav'yalov A.N.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.V.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M.B., Galstyan G.R.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antsiferov M.B.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M.B., Petunina N.A., Antsiferov M.B., Petunina N.A.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y.V., Dedov I.I., Mayorov A.Y., Surkova E.V., Dedov I.I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T.Y., Demidova T.Y.
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K.K., Plotnikova O.A., Sharafetdinov K., Plotnikova O.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A.S., Tertychnaya E.A.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
Diabetic distal polyneuropathy: the principles of diagnostics and therapy
Komelyagina E.Y., Antsiferov M.B.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A.F., Tsanava I.A., Verbovaya N.I.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.V.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N.A., Antsiferov M.B.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A.S., Brashchenkova A.V.
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N.V., Kuznetsova A.V., Vorohobina N.V., Kuznetsova A.V.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T.I., Popkova E.N., Trel'skaya N.Y., Emel'yanov V.V., Severina T.I., Popkova Y.N., Trelskaya N.Y., Yemelyanov V.V.
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O.V., Zanozina O.V.
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M.B., Zilov A.V., Antsiferov M.B., Zilov A.V.
101 - 184 of 184 Items << < 1 2 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies